Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
C3.ai CFO Hitesh Lath executed a series of stock transactions in mid-September 2026, selling shares to cover tax obligations from restricted stock unit vesting while also transferring shares to a family trust. These moves occur against a backdrop of the company's first-quarter fiscal 2027 earnings report, which showed revenue declines that met guid…
Thomas D. Brisbin, a director at Willdan Group, Inc., recently sold 4,905 shares of the company’s common stock, generating aggregate proceeds of $389,254. The transactions involved the exercise of previously granted stock options followed by immediate sales. This insider activity occurs against a backdrop of robust financial performance, with Willd…
Executive Vice President and Chief Legal Officer Michael P. Donaldson sold 7,336 shares of EOG Resources on September 11, 2026, realizing over $1.08 million in proceeds. The sale occurs amid a 45% year-to-date equity rally, robust second-quarter earnings beats, and a company-wide outlook that remained unchanged, prompting cautious market pricing.
MGE Energy Inc. director James G. Berbee recently executed a targeted equity acquisition, reinforcing insider positioning within the utility sector. The transaction coincides with a documented leadership succession at Madison Gas and Electric Company, as the company maintains a decades-long dividend growth trajectory and operates near recent valuat…
Horizon Kinetics Asset Management LLC has executed a targeted acquisition of common equity in RENN Fund, Inc., reinforcing its existing operational and financial relationship with the publicly traded investment vehicle. The Delaware-based firm, which serves as the fund’s investment adviser and holds director responsibilities, purchased shares acros…
Life Time Group Holdings, Inc. (NASDAQ:LTH) saw significant insider activity following a robust second-quarter earnings report. Ritadhwaja Jebens Singh, Executive Vice President and Chief Digital Officer, executed a complex transaction involving the exercise of stock options and the immediate sale of shares. This movement occurs against a backdrop …
Steven Ratner, Executive Vice President and Chief Human Resources Officer at Mercury Systems, sold 4,000 shares for approximately $338,030 on September 3, 2026. The transaction takes place against a backdrop of record fourth quarter revenue, a 93.1 percent surge in bookings, and multiple analyst upgrades, despite a slight earnings miss and current …
Flexsteel Industries Inc. director William S. Creekmuir sold 3,100 shares worth approximately $252,891 on September 4, 2026. The transaction occurs as the company reports fourth-quarter earnings that exceed Wall Street forecasts, while analyst sentiment adjusts to reflect current valuation levels and sustained revenue growth.
Director Eric L. Oliver acquired $68,085 in CRT units across two trading days in September 2026, raising SoftVest LP's indirect stake to 976,237 units. The purchases coincide with the trust trading near its 52-week high, a 46% year-to-date gain, and a 7.3% dividend yield sustained over 35 consecutive years.
Hyperscale Data Inc CEO William Horne recently purchased $31,220 worth of Class A Common Stock, bringing his direct holdings to 300,000 shares. The transactions coincide with a heavily discounted market valuation, ongoing AI infrastructure deployments, and a strategic pivot involving treasury Bitcoin holdings and subsidiary divestitures.
Donegal Mutual Insurance Co systematically increased its equity position in Donegal Group Inc through targeted share purchases in early September 2026. The transaction coincides with a period of strengthened operational efficiency, robust quarterly earnings expansion, and a combined ratio improvement that underscores enhanced underwriting disciplin…
Mark D. Walker, chairman and chief executive officer of Direct Digital Holdings, Inc., executed a $4,315 sale of 2,136 shares across September 1 and 2, 2026. The transaction follows a disappointing second quarter where adjusted earnings per share of negative $5.78 and revenue of $7.83 million both fell short of Wall Street estimates, triggering an …
Gregory Martin Smith, Senior Executive Vice President and President of Commercial Banking at Peapack Gladstone Financial Corp (NASDAQ: PGC), executed a stock sale of 1,250 shares on September 2, 2026. The transaction, valued at $55,824 based on a $44.66 share price, reduces his direct holding to 12,622 shares. The sale occurs while PGC stock trades…
Matthew M. Kim, Comptroller at Southern Co, executed a transaction involving 100 shares on September 1, 2026, selling at $88.45 per share for a total of $8,845. This move follows a second-quarter earnings report that demonstrated earnings per share strength despite a revenue shortfall. The utility operator continues to see its shares trade near rec…
Horizon Kinetics Holding Corp (NASDAQ: HKHC) is navigating a complex financial environment marked by valuation opportunities and operational volatility. Following a recent insider purchase by board director Alice C. Brennan, market participants are evaluating the firm’s underlying cash position against recent earnings fluctuations. The transaction …
The recent share divestment by RxSight's chief financial officer reflects routine restricted stock unit vesting and associated tax withholding procedures rather than discretionary market positioning. This corporate transaction unfolds alongside stronger-than-expected second-quarter earnings, yet it is counterbalanced by the suspension of full-year …
Dr. Ronald M. Kurtz, Chief Medical Officer at RxSight, Inc., executed a targeted divestment of 5,100 shares on September 2, 2026, to satisfy tax withholding requirements linked to restricted stock unit vesting. The transaction reflects standard compensation mechanics rather than discretionary market timing. Current market pricing sits at $7.03, whi…
Kelly Gold, chief financial officer at Camp4 Therapeutics Corp, purchased 10,000 shares valued at $39,600 on August 31, 2026, while maintaining strict governance boundaries regarding account control. The transaction occurs against a backdrop of significant year-over-year appreciation, recent analyst upgrades, and cross-company leadership appointmen…
Michael Simanovsky, a director and substantial shareholder in Sonida Senior Living, Inc. (NASDAQ:SNDA), alongside Conversant Capital LLC, recently executed a series of common stock sales totaling approximately 4.76 million. The divestitures, conducted on August 28 and September 1, 2026, involved 123,988 shares traded between 38.00 and 39.31 per sha…
CrowdStrike Holdings Inc. (NASDAQ: CRWD) registered a targeted insider transaction on August 28, 2026, when President and Chief Executive Officer George Kurtz sold 200 shares of Class A common stock. The divestment, executed through a pre-arranged 10b5-1 trading protocol established on January 6, 2026, totaled $45,167. Shares were offloaded at pric…
Nuo Therapeutics Inc. leadership has executed additional open market purchases, reflecting continued executive engagement with the company's equity structure. David Emerson Jorden, serving as both chief executive officer and chief financial officer, recently expanded his direct beneficial ownership through two separate transactions. The acquisition…
Nicholas S. Schorsch, a director and ten percent shareholder of American Strategic Investment Co., has increased his equity stake through targeted open-market purchases totaling $67,450. The transactions were executed across two consecutive days in late August 2026 while the stock traded at significantly depressed valuation multiples.
NVE Corp director Daniel A. Baker recently executed a series of equity sales totaling $623,217, reducing his direct stake while the company reports accelerated financial growth and a sharp run-up in share valuation. The transactions unfold as NVEC navigates strong gross margins and rapid revenue expansion, though current pricing metrics suggest pot…
Edwards Lifesciences reported a $113,416 insider share sale by its JAPAC Corporate Vice President, while the company simultaneously delivered strong second-quarter financial results, raised full-year guidance, and received multiple analyst upgrades driven by robust production output and TAVR revenue momentum.
Executive equity acquisition signals internal positioning amid recent operational adjustments and earnings misses. Second-quarter financial results diverged from consensus forecasts, prompting the strategic withdrawal of full-year revenue guidance. Margin expansion and unit volume growth in core segments contrast sharply with significant declines i…
